Platelet 5-HT levels and hypothalamic-pituitary-adrenal axis activity in schizophrenic patients with positive and negative symptoms

Neuropsychobiology

Volumn 36, Issue 1, 1997, Pages 19-21

  Pivac, Nela ^a,c   Mück Šeler, Dorotea ^a,c   Jakovljević, Miro ^b,c  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b University Psychiatric Clinic   (Croatia)

^c Croatian Brain Research Institute   (Croatia)

Author keywords

Dexamethasone suppression test; Plasma cortisol levels; Platelet 5 HT concentrations; Positive and negative symptoms; Schizophrenia

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; SEROTONIN;

ADULT; ARTICLE; CELL LEVEL; DEXAMETHASONE SUPPRESSION TEST; HUMAN; HUMAN CELL; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SCHIZOPHRENIA; SYMPTOM; THROMBOCYTE;

ADULT; AROUSAL; BLOOD PLATELETS; DELUSIONS; DEPRESSION; DEXAMETHASONE; DIAGNOSIS, DIFFERENTIAL; HALLUCINATIONS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; PITUITARY-ADRENAL SYSTEM; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEROTONIN;

EID: 0030966625     PISSN: 0302282X     EISSN: 14230224     Source Type: Journal    
DOI: 10.1159/000119354     Document Type: Article

References (21)

1. Breier A: Serotonin, schizophrenia and antipsychotic drug action, Schizophr Res 1995; 14: 187-202.
2. Iqbal N, van Praag HM: The role of serotonin in schizophrenia, Eur Neuropsychopharmacol 1995(suppl): 11-23.
3. Fuller RW: Serotonin receptors and neuroendocrine responses, Ncuropsychopharmacology 1990:3:495-502.
4. Dinan TG: Serotonin and the regulation of hypothalamic-pituitary-adrcnal axis function, LifeSci 1996:58:1683-1694.
5. Tandon R, Mazzara C, Dc Quardo J, Craig KA, Mcador-Woodruff JH, Goldman R, Grcdcn JF: Dexamethasone suppression test in schizophrenia: Relationship to symptomatology, ventricular enlargement and outcome, Biol Psychiatry 1991;29:953-964.
6. Stahl SM: Platelets as pharmacological models for the receptors and biochemistry of mono-aminergic neurons; in Longcneckcr GL (ed): Platelets: Physiology and Pharmacology, New York, Academic Press, 1985. pp 307-340.
7. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3. revised (DSM-U1-R), Washington, APA, 1987.
8. Muck-Seier D, Jakovljevic M, Deanovii W: Time course of schizophrenia and platelet 5-HT, Biol Psychiatry 1988;23:243-251.
9. Lowry OH, Rosebrough NS, Farr AC, Randall RJ: Protein measurement with the Folin phenol reagent, J Biol Chem 1951:193:265-275.
10. Jakovljevic M, Mück-Seler D, Kenfelj H, Plav SUV, Bioiina S, Kastralovic D, Ljubifie D: Basal cortisol, dexamethasone suppression test and platelet 5-HT in recurrent (unipolar) major depression, schizophrenia and schizoaffective disorder, PsychiatrDan 1991;3:389-414.
11. Jakovljevic M, Mück-Seler D, Pivac N, Ljubiüc D, Bujas M, Dodig G: Seasonal influence on platelet 5-HT levels in patients with recurrent major depression and schizophrenia, Biol Psychiatry, in press.
12. Owens MJ, Nemeroff CB: Physiology and pharmacology of corticotropin-releasing factor, Pharmacol Rev 1991;43:425-473.
13. Lamnters CH, Garcia-Borreguero D, Schmider J, Gotthard U, Dettling M, Holsboer F, Heuser IJE: Combined dexamethasone/corticotropin-releasing hormone lest in patients with schizophrenia and in normal controls: II, Biol Psychiatry 1995;38:803-807.
14. Banki CM, Bissette G, Aralo G, O'Connor L, Nemeroff CB: CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia, Am J Psychiatry 1987; 144:873-877.
15. Lerer B, Ran A, Blacker M, Silver H, Weller MPI, Drummer D, Ebstein B, Calev A: Neuroendocrine responses in chronic schizophrenia, Schizophr Res 1988:1:405-410.
16. Kaneko M, Murata S, Hoshino Y, Takahagi K, Yokoyama F, Watanabe M, Kumashiro H: Dexamethasone suppression test in schizophrenia: Its relation to monoamine metabolism in hvpothalamic-pituitary-adrenal axis, Neuropsychobiology 1990;24:12-16.
17. Tandon R, Silk KR, Grcden JF, Goodson J, Hariharan M, Meador-Woodruff JH, Kronfol Z: Positive and negative symptoms in schizophrenia and the dexamethasone suppression test, Biol Psychiatry 1989:25:785-788.
18. Baumgartner A, Graf K-J, Kürten I: The dexamethasone suppression test in depression, in schizophrenia, and during experimental stress, Biol Psychiatry 1985;20:675-679.
19. Keitner GI, Ryan CE, Kohn R, Miller IW, Norman WH, Brown WA: Age and dexamethasone suppression test: Results from a broad unsclect-ed patients population, Psychiatry Res 1992; 44:9-20.
20. Arena GW, Baldessarini RJ: Clinical use of the dexamethasone suppression test in psychiatry; in Meltzer HY (ed): Psychopharmacology: The Third Generation of Progress, New York, Raven Press, 1987. pp 609-615.
21. Kendler KS: Phenomenology of schizophrenia, Drug Dev Res 1986;9:3-8.